| Data | Hora | Fonte | Título | Código | Companhia |
| 27/04/2012 | 17:18 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/04/2012 | 15:40 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/04/2012 | 18:08 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/04/2012 | 14:45 | Zacks | Bad News for Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/04/2012 | 11:11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/04/2012 | 10:54 | Business Wire | Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in Europe | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/04/2012 | 17:59 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/04/2012 | 09:15 | Business Wire | Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/04/2012 | 07:04 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/04/2012 | 07:04 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 13/04/2012 | 18:24 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 13/04/2012 | 18:11 | Edgar (US Regulatory) | Amended Annual Statement of Changes in Beneficial Ownership (5/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/04/2012 | 12:26 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/04/2012 | 09:15 | Zacks | Allos Eyed by Spectrum Pharma - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/04/2012 | 06:06 | Zacks | Company News for April 9, 2012 - Corporate Summary | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/04/2012 | 07:07 | Edgar (US Regulatory) | Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 18:23 | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 15:07 | Dow Jones News | UPDATE: Amid Setback, Spectrum Pharma To Buy Allos For $206 Million | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 11:28 | PR Newswire (US) | Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum ... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 09:52 | PR Newswire (US) | Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger w... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 08:00 | Business Wire | Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/03/2012 | 05:14 | Zacks | Zacks #1 Rank Additions for Friday - Tale of the Tape | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/03/2012 | 07:03 | Edgar (US Regulatory) | Amended Quarterly Report (10-Q/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 22/03/2012 | 07:00 | Zacks | Allos Upped to Outperform - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/03/2012 | 05:15 | Zacks | Allos Narrows Loss - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/03/2012 | 18:00 | Business Wire | Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 20:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 19:48 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/02/2012 | 21:19 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 21/02/2012 | 11:00 | Business Wire | Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |